Skip to main content
. 2017 Nov 1;8:1324. doi: 10.3389/fimmu.2017.01324

Table 2.

Dex-mesylate (Dex-Mes) and selective glucocorticoid receptor agonist (SEGRA) compounds 1217 and 1218 but not GSK866 or Dex covalently bind glucocorticoid receptor ligand-binding domain (GR-LBD)-specific cysteines.

Sample Modifications
Ctrl
Dex
Dex-Mes Peptide 615–633 → C622
GSK866
1217 Peptide 615–633 → C622
1218 Peptide 615–633 → C622

MassspecMass spectrometry-based identification of GR-LBD cysteine-containing peptides which bind covalently to SEGRAs GSK866, 1217, or 1218. The position of the LBD peptide in hGR is indicated by the residue numbers of the first and last amino acid of the peptide (according to the SwissProt database). The modified residue is described by the official amino acid acronym and its position in hGR.